中山醫學大學機構典藏 CSMUIR:Item 310902500/24048
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 17929/22944 (78%)
造访人次 : 7474625      在线人数 : 321
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.csmu.edu.tw:8080/ir/handle/310902500/24048


    题名: Geriatric Nutritional Risk Index as a Prognostic Marker for Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel
    作者: Chang, LW;Hung, SC;Li, JR;Chiu, KY;Yang, CK;Chen, CS;Lu, KV;Chen, CC;Wang, SC;Lin, CY;Cheng, CL;Ou, YC;Yang, SF;Hsu, CY;Ho, SH;Wang, SS
    关键词: geriatric nutritional risk index;metastasis castration resistant prostate cancer;chemotherapy;DOCETAXEL;survival
    日期: 2021
    上传时间: 2022-08-05T09:46:59Z (UTC)
    出版者: FRONTIERS MEDIA SA
    ISSN: 1663-9812
    摘要: Purpose: To investigate the prognostic efficacy of the Geriatric Nutritional Risk Index (GNRI) in patients with metastatic Castration-resistant Prostate Cancer (mCRPC) receiving docetaxel as the first line of treatment. Methods: We retrospectively reviewed patients with mCRPC and receiving first line docetaxel in Taichung Veterans General Hospital from 2006 to 2012. The GNRI was calculated using serum albumin and body mass index, with a poor nutritional status defined as GNRI Results: One-hundred seventy patients with mCRPC were included. One-hundred twenty-five patients were of normal nutritional status (GNRI >= 92) and 45 patients were of poor nutritional status (GNRI <92). The cumulative docetaxel dosage was 600 (360-1,185) mg in the normal nutritional status group and 360 (127.5-660) mg in the poor nutritional status group (p < 0.001). The median overall survival from mCRPC was 30.39 months in the good nutritional status group and 11.07 months in the poor nutritional status group (p of log rank <0.001). In a multivariate model, poor nutritional status was an independent risk factor in overall survival (Hazard Ratio [HR] = 5.37, 95% Confidence Interval [CI] 3.27-8.83), together with a high metastatic volume (HR = 4.03, 95% CI 2.16-7.53) and docetaxel cumulative dosage (HR = 0.999, 95% CI 0.999-0.9998). Conclusion: Poor nutritional status with a GNRI <92 is associated with shorter progression free survival and overall survival in mCRPC patients treated with docetaxel. Metastatic volume and cumulative docetaxel dosage are also independent prognostic factors in overall survival.
    URI: http://dx.doi.org/10.3389/fphar.2020.601513
    https://www.webofscience.com/wos/woscc/full-record/WOS:000615720300001
    https://ir.csmu.edu.tw:8080/handle/310902500/24048
    關聯: FRONTIERS IN PHARMACOLOGY ,2021,v11
    显示于类别:[中山醫學大學研究成果] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML176检视/开启


    SFX Query

    在CSMUIR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈